About Us

Making Advanced Mental Health Treatment Feel Safe and Understandable

At Braxia Health, we’re committed to making advanced mental health care feel understandable, accessible, and safe.

We bridge two essential worlds: the precision of clinical science and the emotional reality of living with mental health challenges.

  • Modern treatment, made clear
  • Grounded in Clinical Precision
  • Connected to Real Human Emotions
  • You’re Never Alone
READ MORE

Refer a Patient for Advanced Mental Health Care

REFER A PATIENT ONLINE REFERAL FORM

Patient Experience

Psychedelic Therapy for Depression

Many patients report meaningful improvements in depression symptoms after just a few psychedelic therapy sessions. The experience often helps individuals gain new perspectives, release emotional blocks, and reconnect with a deeper sense of purpose and well-being. While the results can be significant, every journey is unique: some notice rapid changes, while others experience more gradual growth over time. It’s important to remember that not everyone responds to psychedelic therapy in the same way. Careful guidance and professional support ensure the process remains safe, personalized, and transformative.

Psychedelic
Everything You Need to Know

Everything You Need to Know

Frequently Asked Questions

We translate research, protocols, and clinical data into clear, compassionate language. We show our process. We show our credibility. We show the level of care behind every step.

The long-term efficacies in individuals who have responded to this treatment modality are not yet fully known. Emerging evidence indicates that some individuals remain well for several months. Undoubtedly, there will be some individuals who remain well for longer periods of time. It’s also known that other individuals will require booster sessions to maintain their feelings of wellness. The booster sessions are typically administered approximately once per month, depending on the chosen molecule.

This depends on the drug and will be assessed by our physicians during the intake process. Generally:

  • Any individual who has a primary diagnosis is anything other than MDD or BD. As noted above, individual consideration will be given on a case-by-case basis for adults with either PTSD or OCD.
  • Individuals who meet DSM-5 criteria for a substance use and or alcohol use disorder
  • Any individual who has met DSM-5 criteria for a Substance Use Disorder and/or alcohol use disorder in the past 3 months.
  • All individuals who use illicit substances (but do not meet criteria for Substance Use Disorder according to the DSM-5 criteria) must refrain from using substances for a minimum of one month prior to their first infusion at Braxia Health.
  • Individuals who are experiencing psychotic symptoms as part of an MDE (mood congruent/mood incongruent)
  • Individuals with a dementing disorder (e.g., Alzheimer’s disease)
  • Individuals who are unable to provide written consent to the treatment
  • Individuals who are unable to adhere to the protocol in its totality (i.e., remain in the clinic post infusion for a minimum of 20 minutes or as advised by the medical team for observation).
  • Individuals who are unable to identify a person to ensure their safe transport to home post infusion
  • Individuals with symptomatic traumatic brain injury
  • Uncontrolled medical disorders (i.e., uncontrolled and/or insufficiently treated hypertension, allergies to the drug and/or previous intolerability of the drug)
  • Pregnancy
  • Medical contraindications to the molecule (e.g. epilepsy)
  • Patients that are over 275 lbs.
  • Patients who do not adhere to Braxia Health protocol with respect to chaperoning during the visit and post-discharge
  • Individuals will be ineligible for treatment if they are not a Canadian resident
  • Any patient who does not have a community MRP will not be accepted for assessment or any procedure at Braxia Health.
  • Any individual who exhibits aggressive or intimidating behaviour towards Braxia Health staff or other patients will not be eligible for treatment at Braxia Health.
  • Any patient who does not adhere to all pre-procedure recommendations (e.g., food fasting) is not eligible for treatment at Braxia Health.
  • Patients feeling acutely unwell for any reason (e.g. symptoms of infection) and/or have come into direct contact with someone acutely ill from a transmissible infection.
Intravenous (IV) Psychedelic Therapy

Intravenous (IV) Psychedelic Therapy

LEARN MORE
Sublingual Virtual Psychedelic Therapy

Sublingual Virtual Psychedelic Therapy

LEARN MORE
Intravenous Psychedelic

Why Choose Intravenous (IV) Treatment

Intravenous Psychedelic Therapy

Intravenous Psychedelic Therapy is an advanced mental health therapy where medication is delivered directly into the bloodstream through an IV infusion. This method allows for rapid relief in many patients from Major Depressive Disorder, Bipolar Disorder, PTSD, and some other treatment-resistant mood disorders.

During the session, patients are monitored by trained clinicians to ensure safety, precision dosing, and a comfortable experience. The treatment works by activating NMDA receptors and boosting neuroplasticity, helping the brain form new, healthier pathways. Many people experience improvements in mood and reduced symptoms within hours to days, making it one of the fastest-acting psychiatric treatments available.

Virtual Sublingual Psychedelic Therapy

Sublingual Lozenges

Virtual Sublingual Psychedelic Therapy

The medication is compounded into an oral tablet that dissolves under your tongue. The medication is used off-label for treatment resistant depression. Initial clinical trials have shown promising results; however delivery, oral ketamine is less studied compared to IV and nasal delivery.

Sublingual psychedelic therapy is associated with significant dissociative effects, similar to IV therapy. Both delivery methods include specialized 1:1 supervision with trained healthcare practitioners to ensure a safe and supported experience.

Where Clinical Expertise Meets Genuine Human Care

At Braxia Health, we combine the strength of clinical expertise with genuine empathy. We take complex research, protocols, and clinical data and translate them into clear, compassionate guidance so you always understand your care.

Rectangle 147

Psychedelic therapy provides fast-acting relief for individuals struggling with major depression and bipolar disorder. Many patients notice significant improvements in mood and energy after just a few sessions. The treatment is administered in a safe and supportive environment after patients are throughly evaluated and screened for appropriateness.

Rectangle 150

We’ve seen patients who struggle with depression for years see significant improvements following treatment. More than anything else, we are passionate about this therapy because it has the potential to change lives. We live and breathe it every day.

Begin Your Healing Journey with Braxia Health

Start The Process

Take the first step toward feeling better with a simple, secure consultation. Our clinical team reviews your symptoms and history to determine if ketamine therapy is psychedelic right fit for you.

Choose a Treatment Plan

At Braxia Health, we create a personalized treatment plan based on your consultation. Our team recommends the right care from psychedelic therapy to ongoing support ensuring safe, effective, and long-term healing.
Begin Treatment

Begin Treatment

Begin your healing journey at Braxia Health, where our clinical team guides each treatment session with care and close monitoring. Every visit is focused on your safety, comfort, and steady progress toward lasting wellness.

Bringing Balance to Better Mental Health

At Braxia Health, we make science easy to understand, support easy to access, and mental health care deeply human offering clear, compassionate, evidencebased care at every step.

Our Approach

Everything we publish should reinforce that Braxia is both:

Trust the Oldest Clinic in Canada

Why Choose Braxia Health

Trust the Oldest Clinic in Canada

Back in 2018, our team was the first in Canada to offer the specific type of psychedelic therapy we are known for. Up until that point, it simply wasn’t available, even for the most complex mental health situations. That’s why we continue to conduct and publish research, refine our approach, and launch new programs to better support patient accessibility, like at-home virtual sublingual psychedelic therapy. We’re proud of what we do.